Of the remaining 18 patients where ERS criteria could not make a definite diagnosis without lung biopsy, six of these had a VEGF-D level of >800 pg/ml suggesting a further 10% of patients could avoid lung biopsy for a definite diagnosis of LAM were this criteria to be added to diagnostic guidelines (Figure 3). The gene discussed is VEGFD; the disease is lymphangioleiomyomatosis.